Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 40 Carcinoma, Non-Small-Cell Lung 32 Colorectal Neoplasms 27 Ovarian Neoplasms 23 Neoplasms 23 Lung Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Pancreatic Neoplasms 17 Leukemia, Myeloid, Acute 16 Head and Neck Neoplasms 16 Lymphoma, Non-Hodgkin 15 Neoplasm Metastasis 14 Fallopian Tube Neoplasms 14 Glioblastoma 13 Esophageal Neoplasms 12 Rectal Neoplasms 11 Lymphoma 11 Squamous Cell Carcinoma of Head and Neck 10 Central Nervous System Neoplasms 10 Carcinoma, Ovarian Epithelial 10 Recurrence 9 Melanoma 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Follicular 9 Leukemia 9 Stomach Neoplasms 8 Prostatic Neoplasms 8 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell, Marginal Zone 7 Liver Neoplasms 7

Interventions

Gemcitabine 8 130-nm albumin-bound paclitaxel 5 Albumin-Bound Paclitaxel 4 napabucasin 2 Oxaliplatin 2 MK-4721 2 Leucovorin 2 Fluorouracil 2 Carboplatin 2 tremelimumab 1 irinotecan sucrosofate 1 ensituximab 1 durvalumab 1 contrast agent BR1 1 cc-486 1 Taxes 1 Practice Guidelines as Topic 1 Pancreaticoduodenectomy 1 Paclitaxel 1 PEGPH20 1 Lead 1 Irinotecan 1 Enoxaparin 1 EC regimen 1 Drug Therapy 1 Dexamethasone 1 Cisplatin 1 CP protocol 1 Azacitidine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Pancreatic Ductal × Drug Therapy × Clear all

NCT04146441 2023-01-19

PDAC

St. Olavs Hospital

Phase 2 Completed

Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡